Molecular Partners Announces Workforce Reduction to Extend Cash Runway

Molecular Partners ( (MOLN) ) has shared an announcement.

On June 10, 2025, Molecular Partners AG announced a strategic review of its operations, resulting in a planned workforce reduction of up to 40 positions, approximately 24% of its staff, to enhance organizational efficiency and focus on advancing its clinical assets. This restructuring is expected to extend the company’s cash runway into 2028, supporting the development of its clinical programs, including MP0533 and MP0712, with clinical milestones anticipated in the second half of 2025. The company is committed to supporting affected employees through severance packages and assistance in finding new employment opportunities.

The most recent analyst rating on (MOLN) stock is a Hold with a $5.40 price target. To see the full list of analyst forecasts on Molecular Partners stock, see the MOLN Stock Forecast page.

Spark’s Take on MOLN Stock

According to Spark, TipRanks’ AI Analyst, MOLN is a Neutral.

Molecular Partners faces substantial financial difficulties, with negative profitability and sustainability concerns being the most significant factors. Despite some positive strategic developments and a strong financial runway highlighted in the earnings call, the overall outlook is overshadowed by financial performance challenges and weak technical indicators.

To see Spark’s full report on MOLN stock, click here.

More about Molecular Partners

Molecular Partners AG is a clinical-stage biotech company that specializes in developing DARPin therapeutics, a novel class of protein drugs aimed at addressing medical challenges that other drug modalities cannot easily tackle. The company focuses primarily on oncology and has various programs in preclinical and clinical development stages. Founded in 2004, Molecular Partners operates out of Zurich, Switzerland, and Concord, Massachusetts, USA, and collaborates with leading pharmaceutical companies to deliver unique solutions to patients.

Average Trading Volume: 10,703

Technical Sentiment Signal: Sell

Current Market Cap: $151.7M

For a thorough assessment of MOLN stock, go to TipRanks’ Stock Analysis page.